Preventive effects of Daisaikoto on metabolic disorders in spontaneous obese type II diabetes mice

Journal of Traditional Medicines

Volumn 23, Issue 6, 2006, Pages 216-223

  Tsunakawa, Mitsuo ^a   Shimada, Tsutomu ^b   Suzuki, Wataru ^b   Nagata, Mitsunobu ^b   Takeda, Shuichi ^b   Mizuno, Asako ^b,c   Kosugi, Mitsutaka ^b   Aburada, Masaki ^b  

^a KANAZAWA UNIVERSITY   (Japan)

^b MUSASHINO UNIVERSITY   (Japan)

^c NIPPON VETERINARY AND LIFE SCIENCE UNIVERSITY   (Japan)

Author keywords

Daisaikoto; diabetic complication; metabolic disorders; Metabolic syndrome; TSOD mice; visceral fat

Indexed keywords

EID: 46449088364     PISSN: 18801447     EISSN: 18813747     Source Type: Journal    
DOI: 10.11339/jtm.23.216     Document Type: Article

References (25)

1. Kuzuya, K.: What is metabolic syndrome? Kampo & the Newest Therapy, 14 (1), 7-11, 2005.
2. Tashiro, S.: Metabolic syndrome and Kampo drugs. Kampo & the Newest Therapy, 14 (1), 49-53, 2005.
3. Committee to Establish Diagnosis Criteria for Metabolic Syndrome.: Definition of and diagnosis criteria for metabolic syndrome. Internal Medicine, 94 (4), 188-203, 2005.
4. Mitani, K.: Metabolic syndrome and Kampo therapy. Kampo & the Newest Therapy, 14 (1), 43-47, 2005.
5. Kuwaki, T.: Kampo therapy handbook, 171-172, 1987.
6. Suzuki, W.: TSOD mice. Diabetes Frontier, 9 (4), 485-488, 1998.
7. Suzuki, E., Iizuka, S., Tabuchi, M., Funo, S., Yanagisawa, T., Kimura, M., Sato, T., Endo, T. and Kawamura, H.: A new mouse model of spontaneous diabetes derived from ddy strain. Exp. Anim., 48 (3), 181-189, 1999.
8. Suzuki, W and Tabuchi, M.: A new spontaneous Type II diabetes model, TSOD mice (1): Concerning the disease status. Laboratory Animal Technology and Science, 11 (2), 99-103, 1999.
9. Suzuki, W., Iizuka, S., Tabuchi, M., Yanagisawa, T., Kimura, M.: TSOD mice, a new spontaneous Type II diabetes model. Diabetes Frontier, 13 (1), 106-108, 2002.
10. Iizuka, S., Suzuki, W., Tabuchi, M., Nagata, M., Imamura, S, Kobayashi, Y., Kanitani, M., Yanagisawa, T., Kase, Y., Takeda, S., Aburada, M. and Takanashi, K.: Diabetic complications in a new animal model (TSOD mouse) of spontaneous NIDDM with obesity. Exp. Anim., 54 (1), 71-83, 2005.
11. Suzuki, W and Nakajima, H.: Metabolic syndrome-related disease status of TSOD mouse. Laboratory Animal Technology and Science, 17 (4), 112-118, 2005.
12. Suzuki, W., Iizuka, S., Hiruta, M., Sadagane, K., Tabuchi, M., Funo, S., Kimura, M., Kawamura, H.: General behavior, movement and perceptive function of TSOD mouse, NIDDM model animal. Diabetes Frontier, 10 (4), 603-604, 1999.
13. Otsuka, K.: Kampo-medicine, Sougensha, Osaka, p. 134, 1987.
14. Umeda, M., Amagaya, S. and Ogihara, Y.: Effects of Syosaikoto and Daisaikoto on experimental atherosclerosis in rabbits. J. Trad. Med., 5 (2), 154, 1988.
15. Goto, M., Inoue, H., Seyama, Y., Yamashita, S., Inoue, O. and Yumioka, E.: Comparative effect of traditional Chinese medicine (Daisaikoto, Hachimiziogan and Byakkokaninzinto) on experimental diabetes and hyperlipidemia. Folia Pharmacol. Japon, 93, 179-186, 1989.
16. Ohminami, K., Matsuoka, E., Inada, K. and Okuda, T.: Effect of Daisaikoto and Inchinkoto on gold thioglucose-induced obese mice. Jpn Pharmacol. Ther., 12, 3905-3912, 1984.
17. Ohminami, K., Matsuoka, E. and Okuda, T.: Effect of Daisaikoto on hyperlipidemia. Jpn Pharmacol. Ther., 13 (9), 5091-5095, 1985.
18. Nakajima, H., Hara, K., Kobayashi, T., Suzuki, W. and Aburada, M.: Reevaluation of TSOD mice as an Animal Model of Metabolic Syndrome. J. Metabolic Syndrome, 2 (1), 42-46, 2005.
19. Gotoda, T.: Molecular mechanism of multiple-risk-factor syndrome. Diabetes Complications, 17, 43-49, 2003.
20. Gotoda, T.: Management of metabolic syndrome: meaning of metabolic syndrome. J. Jpn. Medical Association, 131, 180-185, 2004.
21. Ikeda, H., Fukushima, M. and Seino, Y.: Abnormality of body fat volume and distribution. Nippon Rinsho, 61. Supl. 6, 419-423, 2003.
22. Yamada, T., Yoshimura, M., Katsura, Y., Kinukawa, N., Kusunoki, M., Nakamura, M., Sakurai, I, Kato, N., Mitsui S., Tochihara, T., Yasugi, T. and Ohtsuka Y.: Study on effect of Daisaikoto on arteriosclerosis. Arteriosclerosis, 19 (2, 3), 209-218, 1991.
23. Ohminami, K., Matsuoka, E. and Okuda, T.: Effect of Daisaikoto on the intestinal absorption of lipid. Jpn Pharmacol. Ther., 13 (9), 5097-5099, 1985.
24. Yoshikawa, A., Mugitani, K., Iwane, M. and Mohara, O.: Hypertension, Nippon Rinsho, 61. Suppl. 6, 448-452, 2003.
25. Yoshida, T., Sakane, N and Umekawa, T.: Future therapy of obesity (including intractable obesity). Diabetes and Vessel, 4 (1), 109-119, 1999.